Glass House Brands (GLAS) Cash from Investing Activities (2020 - 2026)

Glass House Brands' (GLAS) quarterly Cash from Investing Activities came in at -$2.7 million in Q1 2026, up 58.98% year-on-year from -$1.7 million in Q1 2025, and down 26.08% on a QoQ basis from -$2.2 million in Q4 2025.

Glass House Brands (GLAS) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Cash from Investing Activities data on file, last reported at -$2.7 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 58.98% year-over-year to -$2.7 million in Q1 2026; TTM through Mar 2026 was -$23.8 million, a 63.14% decrease from a year earlier, with the FY2025 full-year figure at -$27.7 million, down 169.5% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$2.7 million, down from -$2.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for GLAS reached as high as $13.0 million in Q1 2022 and fell as low as -$12976.5 billion in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$1143.1 billion across 5 years, with a median of -$2.4 million in 2024.
  • Across the five-year window, Cash from Investing Activities soared 2198.29% in 2022 and sank 19738531056.36% in 2023, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$12976.5 billion in 2022, then surged by 100.0% to $6.3 million in 2023, then slumped by 140.91% to -$2.6 million in 2024, then gained by 14.92% to -$2.2 million in 2025, then decreased by 26.08% to -$2.7 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.7 million in Q1 2026, -$2.2 million in Q4 2025, and -$9.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -2.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.75 Mn
Mar 31, 2026 -2.75 Mn
Dec 31, 2025 -2.18 Mn
Dec 31, 2025 -2.18 Mn
Sep 30, 2025 -9.60 Mn
Sep 30, 2025 -9.60 Mn
Jun 30, 2025 -9.27 Mn
Jun 30, 2025 -9.27 Mn
Mar 31, 2025 -6.70 Mn
Mar 31, 2025 -6.70 Mn
Dec 31, 2024 -2.56 Mn
Dec 31, 2024 -2.56 Mn
Sep 30, 2024 -1.42 Mn
Sep 30, 2024 -1.42 Mn
Jun 30, 2024 -3.91 Mn
Jun 30, 2024 -3.91 Mn
Mar 31, 2024 -2.41 Mn
Mar 31, 2024 -2.41 Mn
Dec 31, 2023 6.26 Mn
Dec 31, 2023 6.26 Mn